Corrigendum to 'Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease' EBioMedicine 47 (2019) 446-456

doi:10.1016/j.ebiom.2019.12.004

Published Erratum

. 2020 Feb:52:102595.

doi: 10.1016/j.ebiom.2019.12.004. Epub 2020 Jan 23.

Corrigendum to 'Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease' EBioMedicine 47 (2019) 446-456

LaTonya J Hickson¹, Larissa G P Langhi Prata², Shane A Bobart³, Tamara K Evans⁴, Nino Giorgadze², Shahrukh K Hashmi⁵, Sandra M Herrmann³, Michael D Jensen⁶, Qingyi Jia⁶, Kyra L Jordan³, Todd A Kellogg⁷, Sundeep Khosla⁸, Daniel M Koerber², Anthony B Lagnado⁹, Donna K Lawson¹⁰, Nathan K LeBrasseur¹¹, Lilach O Lerman³, Kathleen M McDonald¹², Travis J McKenzie⁷, João F Passos⁹, Robert J Pignolo¹³, Tamar Pirtskhalava², Ishran M Saadiq³, Kalli K Schaefer², Stephen C Textor³, Stella G Victorelli⁹, Tammie L Volkman⁴, Ailing Xue², Mark A Wentworth¹², Erin O Wissler Gerdes⁴, David B Allison¹⁴, Stephanie L Dickinson¹⁴, Keisuke Ejima¹⁴, Elizabeth J Atkinson¹⁵, Marc Lenburg¹⁶, Yi Zhu², Tamara Tchkonia¹⁷, James L Kirkland¹⁸

Affiliations

¹ Cellular Senescence and Translation and Pharmacology Programs, Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, United States; Division of Geriatric Medicine and Gerontology, Department of Medicine, Mayo Clinic, Rochester, MN, United States; Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, United States.
² Cellular Senescence and Translation and Pharmacology Programs, Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, United States.
³ Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, United States.
⁴ Cellular Senescence and Translation and Pharmacology Programs, Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, United States; Department of Medicine Clinical Trials Unit, Department of Medicine, Mayo Clinic, Rochester, MN, United States.
⁵ Cellular Senescence and Translation and Pharmacology Programs, Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, United States; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, United States.
⁶ Division of Endocrinology, Department of Medicine, Mayo Clinic, Rochester, MN, United States.
⁷ Department of Surgery, Mayo Clinic, Rochester, MN, United States.
⁸ Cellular Senescence and Translation and Pharmacology Programs, Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, United States; Division of Endocrinology, Department of Medicine, Mayo Clinic, Rochester, MN, United States.
⁹ Cellular Senescence and Translation and Pharmacology Programs, Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, United States; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, United States.
¹⁰ Division of Hospital Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, United States.
¹¹ Cellular Senescence and Translation and Pharmacology Programs, Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, United States; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, United States; Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN, United States.
¹² Cellular Senescence and Translation and Pharmacology Programs, Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, United States; Office of Research Regulatory Support, Mayo Clinic, Rochester, MN, United States.
¹³ Cellular Senescence and Translation and Pharmacology Programs, Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, United States; Division of Geriatric Medicine and Gerontology, Department of Medicine, Mayo Clinic, Rochester, MN, United States; Division of Endocrinology, Department of Medicine, Mayo Clinic, Rochester, MN, United States; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, United States; Division of Hospital Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, United States.
¹⁴ Department of Epidemiology and Biostatistics, School of Public Health, Indiana University - Bloomington, Bloomington, IN, United States.
¹⁵ Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, United States.
¹⁶ Section of Computational Biomedicine, Boston University School of Medicine, Boston, MA, United States.
¹⁷ Cellular Senescence and Translation and Pharmacology Programs, Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, United States. Electronic address: tchkonia.tamar@mayo.edu.
¹⁸ Cellular Senescence and Translation and Pharmacology Programs, Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, United States; Division of Geriatric Medicine and Gerontology, Department of Medicine, Mayo Clinic, Rochester, MN, United States; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, United States; Division of General Internal Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, United States. Electronic address: kirkland.james@mayo.edu.

PMID: 31982828
PMCID: PMC6994619
DOI: 10.1016/j.ebiom.2019.12.004

Published Erratum

Corrigendum to 'Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease' EBioMedicine 47 (2019) 446-456

LaTonya J Hickson et al. EBioMedicine. 2020 Feb.

. 2020 Feb:52:102595.

doi: 10.1016/j.ebiom.2019.12.004. Epub 2020 Jan 23.

Authors

Affiliations

¹ Cellular Senescence and Translation and Pharmacology Programs, Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, United States; Division of Geriatric Medicine and Gerontology, Department of Medicine, Mayo Clinic, Rochester, MN, United States; Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, United States.
² Cellular Senescence and Translation and Pharmacology Programs, Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, United States.
³ Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, United States.
⁴ Cellular Senescence and Translation and Pharmacology Programs, Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, United States; Department of Medicine Clinical Trials Unit, Department of Medicine, Mayo Clinic, Rochester, MN, United States.
⁵ Cellular Senescence and Translation and Pharmacology Programs, Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, United States; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, United States.
⁶ Division of Endocrinology, Department of Medicine, Mayo Clinic, Rochester, MN, United States.
⁷ Department of Surgery, Mayo Clinic, Rochester, MN, United States.
⁸ Cellular Senescence and Translation and Pharmacology Programs, Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, United States; Division of Endocrinology, Department of Medicine, Mayo Clinic, Rochester, MN, United States.
⁹ Cellular Senescence and Translation and Pharmacology Programs, Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, United States; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, United States.
¹⁰ Division of Hospital Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, United States.
¹¹ Cellular Senescence and Translation and Pharmacology Programs, Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, United States; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, United States; Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN, United States.
¹² Cellular Senescence and Translation and Pharmacology Programs, Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, United States; Office of Research Regulatory Support, Mayo Clinic, Rochester, MN, United States.
¹³ Cellular Senescence and Translation and Pharmacology Programs, Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, United States; Division of Geriatric Medicine and Gerontology, Department of Medicine, Mayo Clinic, Rochester, MN, United States; Division of Endocrinology, Department of Medicine, Mayo Clinic, Rochester, MN, United States; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, United States; Division of Hospital Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, United States.
¹⁴ Department of Epidemiology and Biostatistics, School of Public Health, Indiana University - Bloomington, Bloomington, IN, United States.
¹⁵ Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, United States.
¹⁶ Section of Computational Biomedicine, Boston University School of Medicine, Boston, MA, United States.
¹⁷ Cellular Senescence and Translation and Pharmacology Programs, Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, United States. Electronic address: tchkonia.tamar@mayo.edu.
¹⁸ Cellular Senescence and Translation and Pharmacology Programs, Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, United States; Division of Geriatric Medicine and Gerontology, Department of Medicine, Mayo Clinic, Rochester, MN, United States; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, United States; Division of General Internal Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, United States. Electronic address: kirkland.james@mayo.edu.

PMID: 31982828
PMCID: PMC6994619
DOI: 10.1016/j.ebiom.2019.12.004

No abstract available

PubMed Disclaimer

Erratum for

Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease.
Hickson LJ, Langhi Prata LGP, Bobart SA, Evans TK, Giorgadze N, Hashmi SK, Herrmann SM, Jensen MD, Jia Q, Jordan KL, Kellogg TA, Khosla S, Koerber DM, Lagnado AB, Lawson DK, LeBrasseur NK, Lerman LO, McDonald KM, McKenzie TJ, Passos JF, Pignolo RJ, Pirtskhalava T, Saadiq IM, Schaefer KK, Textor SC, Victorelli SG, Volkman TL, Xue A, Wentworth MA, Wissler Gerdes EO, Zhu Y, Tchkonia T, Kirkland JL. Hickson LJ, et al. EBioMedicine. 2019 Sep;47:446-456. doi: 10.1016/j.ebiom.2019.08.069. Epub 2019 Sep 18. EBioMedicine. 2019. PMID: 31542391 Free PMC article.

Cited by

Senolytic therapy for Alzheimer's disease.
Longo FM, Massa SM. Longo FM, et al. Nat Med. 2023 Oct;29(10):2409-2411. doi: 10.1038/s41591-023-02541-y. Nat Med. 2023. PMID: 37758897 No abstract available.
Cellular Senescence and Frailty in Transplantation.
Lorenz EC, Hickson LJ, Khairallah P, Najafi B, Kennedy CC. Lorenz EC, et al. Curr Transplant Rep. 2023 Jun;10(2):51-59. doi: 10.1007/s40472-023-00393-6. Epub 2023 Mar 21. Curr Transplant Rep. 2023. PMID: 37576589
Cellular senescence in skin-related research: Targeted signaling pathways and naturally occurring therapeutic agents.
Dańczak-Pazdrowska A, Gornowicz-Porowska J, Polańska A, Krajka-Kuźniak V, Stawny M, Gostyńska A, Rubiś B, Nourredine S, Ashiqueali S, Schneider A, Tchkonia T, Wyles SP, Kirkland JL, Masternak MM. Dańczak-Pazdrowska A, et al. Aging Cell. 2023 Jun;22(6):e13845. doi: 10.1111/acel.13845. Epub 2023 Apr 11. Aging Cell. 2023. PMID: 37042069 Free PMC article. Review.
Three Tiers to biological escape velocity: The quest to outwit aging.
Palmer RD. Palmer RD. Aging Med (Milton). 2022 Dec 12;5(4):281-286. doi: 10.1002/agm2.12231. eCollection 2022 Dec. Aging Med (Milton). 2022. PMID: 36606268 Free PMC article. Review.
Senolytic Therapy: A Potential Approach for the Elimination of Oncogene-Induced Senescent HPV-Positive Cells.
Saleh T, Khasawneh AI, Himsawi N, Abu-Raideh J, Ejeilat V, Elshazly AM, Gewirtz DA. Saleh T, et al. Int J Mol Sci. 2022 Dec 8;23(24):15512. doi: 10.3390/ijms232415512. Int J Mol Sci. 2022. PMID: 36555154 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

Grants and funding

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Corrigendum to 'Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease' EBioMedicine 47 (2019) 446-456

Affiliations

Corrigendum to 'Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease' EBioMedicine 47 (2019) 446-456

Authors

Affiliations

Erratum for

Similar articles

Cited by

Publication types

Grants and funding

LinkOut - more resources

Full Text Sources